Gavin P. Robertson

10.6k total citations · 1 hit paper
128 papers, 7.2k citations indexed

About

Gavin P. Robertson is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Gavin P. Robertson has authored 128 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Molecular Biology, 28 papers in Oncology and 22 papers in Cancer Research. Recurrent topics in Gavin P. Robertson's work include Melanoma and MAPK Pathways (32 papers), PI3K/AKT/mTOR signaling in cancer (21 papers) and RNA Interference and Gene Delivery (9 papers). Gavin P. Robertson is often cited by papers focused on Melanoma and MAPK Pathways (32 papers), PI3K/AKT/mTOR signaling in cancer (21 papers) and RNA Interference and Gene Delivery (9 papers). Gavin P. Robertson collaborates with scholars based in United States, India and China. Gavin P. Robertson's co-authors include Arati Sharma, SubbaRao V. Madhunapantula, Omer F. Kuzu, Mohammad A. Noory, Raghavendra Gowda, Mark Kester, Mitchell Cheung, David A. Tuveson, Sung Jin Huh and Shantu Amin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Gavin P. Robertson

126 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Role of Cholesterol in Cancer

2016 527 citations Omer F. Kuzu, Mohammad A. Noory et al. Cancer Research profile →

Peers

Countries citing papers authored by Gavin P. Robertson

Since Specialization

Citations

This map shows the geographic impact of Gavin P. Robertson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gavin P. Robertson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gavin P. Robertson more than expected).

Fields of papers citing papers by Gavin P. Robertson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gavin P. Robertson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gavin P. Robertson. The network helps show where Gavin P. Robertson may publish in the future.

Co-authorship network of co-authors of Gavin P. Robertson

This figure shows the co-authorship network connecting the top 25 collaborators of Gavin P. Robertson. A scholar is included among the top collaborators of Gavin P. Robertson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gavin P. Robertson. Gavin P. Robertson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Managing telomerase and telomere dysfunction in acral melanoma 2025 ·Pharmacological Research ·Vishnu Sravan Bollu, Yu‐Chi Chen, Fan Zhang, Krishne Gowda, Shantu Amin, Arun Sharma, Todd D. Schell, Jiyue Zhu, Gavin P. Robertson	1
2	Emerging Role of the p53 Pathway in Modulating NK Cell–Mediated Immunity 2024 ·Molecular Cancer Therapeutics ·Yu‐Chi Chen, Christopher G. Bazewicz, Saketh S. Dinavahi, Nicholas D. Huntington, Todd D. Schell, Gavin P. Robertson	2
3	Polymorphic tandem DNA repeats activate the human telomerase reverse transcriptase gene 2021 ·Proceedings of the National Academy of Sciences ·Tao Xu, De Cheng, Yuanjun Zhao, Jinglong Zhang, Xiaolu Zhu, Fan Zhang, Gang Chen, Yang Wang, Xiufeng Yan, Gavin P. Robertson, Shobhan Gaddameedhi, Philip Lazarus, Shuwen Wang, Jiyue Zhu	7
4	Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents 2019 ·European Journal of Medicinal Chemistry ·Saketh S. Dinavahi, Raghavendra Gowda, Christopher G. Bazewicz, (unknown), Jyh Ming Lin, (unknown), Manoj K. Pandey, Shantu Amin, Gavin P. Robertson, Krishne Gowda	35
5	Development of a Novel Multi-Isoform ALDH Inhibitor Effective as an Antimelanoma Agent 2019 ·Molecular Cancer Therapeutics ·Saketh S. Dinavahi, (unknown), Krishne Gowda, Christopher G. Bazewicz, Venkat R. Chirasani, (unknown), Arthur Berg, Nikolay V. Dokholyan, Shantu Amin, Gavin P. Robertson	26
6	Identification of WEE1 as a target to make AKT inhibition more effective in melanoma 2017 ·Cancer Biology & Therapy ·Omer F. Kuzu, Raghavendra Gowda, Arati Sharma, Mohammad A. Noory, Gregory R. Kardos, SubbaRao V. Madhunapantula, Joseph J. Drabick, Gavin P. Robertson	18
7	The Role of Cholesterol in Cancer breakdown → 2016 ·Cancer Research ·Omer F. Kuzu, Mohammad A. Noory, Gavin P. Robertson	527
8	Nanoparticle-Based Celecoxib and Plumbagin for the Synergistic Treatment of Melanoma 2016 ·Molecular Cancer Therapeutics ·Raghavendra Gowda, Gregory R. Kardos, Arati Sharma, Sanjay Singh, Gavin P. Robertson	53
9	Disruption of Proline Synthesis in Melanoma Inhibits Protein Production Mediated by the GCN2 Pathway 2015 ·Molecular Cancer Research ·Gregory R. Kardos, Hannah C. Wastyk, Gavin P. Robertson	43
10	Nanolipolee-007, a Novel Nanoparticle-Based Drug Containing Leelamine for the Treatment of Melanoma 2014 ·Molecular Cancer Therapeutics ·Raghavendra Gowda, SubbaRao V. Madhunapantula, Arati Sharma, Omer F. Kuzu, Gavin P. Robertson	25
11	Targeting Multiple Key Signaling Pathways in Melanoma Using Leelamine 2014 ·Molecular Cancer Therapeutics ·Raghavendra Gowda, SubbaRao V. Madhunapantula, Omer F. Kuzu, Arati Sharma, Gavin P. Robertson	44
12	Leelamine Mediates Cancer Cell Death through Inhibition of Intracellular Cholesterol Transport 2014 ·Molecular Cancer Therapeutics ·Omer F. Kuzu, Raghavendra Gowda, Arati Sharma, Gavin P. Robertson	66
13	Identification of Aurora Kinase B and Wee1-Like Protein Kinase as Downstream Targets of V600EB-RAF in Melanoma 2013 ·American Journal Of Pathology ·Arati Sharma, SubbaRao V. Madhunapantula, Raghavendra Gowda, Arthur Berg, Rogerio I. Neves, Gavin P. Robertson	31
14	Synthesis and anticancer activity of 4-hydroxy naphtho coumarin derivatives and naphtho coumestans 2013 ·Der pharma chemica ·Shubhangi S. Soman, (unknown), (unknown), Gavin P. Robertson	1
15	Simultaneous Targeting of COX-2 and AKT Using Selenocoxib-1-GSH to Inhibit Melanoma 2012 ·Molecular Cancer Therapeutics ·Raghavendra Gowda, SubbaRao V. Madhunapantula, Dhimant Desai, Shantu Amin, Gavin P. Robertson	48
16	Chemoprevention of Melanoma 2012 ·Advances in pharmacology ·SubbaRao V. Madhunapantula, Gavin P. Robertson	14
17	Targeting sphingosine kinase‐1 to inhibit melanoma 2012 ·Pigment Cell & Melanoma Research ·SubbaRao V. Madhunapantula, Jeremy A. Hengst, Raghavendra Gowda, Todd E. Fox, Jong K. Yun, Gavin P. Robertson	44
18	eEF-2 Kinase Dictates Cross-Talk between Autophagy and Apoptosis Induced by Akt Inhibition, Thereby Modulating Cytotoxicity of Novel Akt Inhibitor MK-2206 2011 ·Cancer Research ·Yan Cheng, Xingcong Ren, Yi Zhang, Rajesh Patel, Arati Sharma, Hao Wu, Gavin P. Robertson, Yan Li, Eric H. Rubin, Jinming Yang	124
19	Macrophage Inhibitory Cytokine-1 Regulates Melanoma Vascular Development 2010 ·American Journal Of Pathology ·Sung Jin Huh, (unknown), Arati Sharma, Gavin P. Robertson	40
20	Targeting Akt3 Signaling in Malignant Melanoma Using Isoselenocyanates 2009 ·Clinical Cancer Research ·Arati Sharma, Arun Sharma, SubbaRao V. Madhunapantula, Dhimant Desai, Sung Jin Huh, Paul J. Mosca, Shantu Amin, Gavin P. Robertson	82

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact